Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Current Pharmaceutical Design|November 14, 2009
Antipsychotic medication: the potential role of 5-HT(1A) receptor agonismAndrew C McCreary, Caitlin A JonesNeuropharmacology|July 16, 2008
Serotonergic approaches in the development of novel antipsychoticsCaitlin A Jones, Andrew C McCrearyCurrent Pharmaceutical Design|June 6, 2015
Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and DrugsAndrew C McCreary, Adrian Newman-TancrediSynapse (New York, N.Y.)|April 7, 2009
Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in ratsMagdalena Zaniewska, Andrew C McCreary, Małgorzata FilipAddiction Biology|October 14, 2014
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aidsWouter Goutier, Margreet Kloeze, Andrew C McCrearyAddiction Biology|November 21, 2013
The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in ratsWouter Goutier, Margreet B Kloeze, Andrew C McCrearyNeuroscience Letters|January 20, 2004
Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in ratsKurt Rasmussen, Andrew C McCreary, Elaine A ShanksBehavioural Brain Research|January 26, 2011
Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological studyEmily Steed, Caitlin A Jones, Andrew C McCrearyInternational Review of Neurobiology|June 14, 2015
Psychostimulants: Basic and Clinical PharmacologyAndrew C McCreary, Christian P Müller, Małgorzata FilipBehavioral Neuroscience|April 24, 2003
Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypesAndrew C McCreary, Malgorzata Filip, Kathryn A CunninghamPageof 6